Published in Comp Hepatol on August 14, 2008
A new treatment strategy for acute liver failure. World J Hepatol (2010) 0.82
Peroxisome Proliferator Activator Receptor (PPAR)- γ Ligand, but Not PPAR- α , Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver. PPAR Res (2014) 0.79
Safety Evaluation of Oral Toxicity of Carica papaya Linn. Leaves: A Subchronic Toxicity Study in Sprague Dawley Rats. Evid Based Complement Alternat Med (2014) 0.79
Antithrombin III injection via the portal vein suppresses liver damage. World J Gastroenterol (2012) 0.78
Ischaemic Markers in Acute Hepatic Injury. J Clin Diagn Res (2016) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci U S A (1994) 4.10
Liver transplantation after paracetamol overdose. BMJ (1991) 2.81
Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology (1998) 1.48
Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol (1994) 1.45
Acute liver failure. Postgrad Med J (2005) 1.42
Fulminant hepatic failure. Liver Transpl (2005) 1.32
Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol (2005) 1.12
Plasma osteopontin levels in patients with fulminant hepatitis. Hepatol Res (2004) 1.07
Selection for acute liver failure: have we got it right? Liver Transpl (2005) 1.06
Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci (2006) 1.01
Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl (1993) 1.00
Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Am J Gastroenterol (2005) 0.96
The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher (2006) 0.95
Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol (1997) 0.95
Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey. Hepatol Res (2004) 0.93
Structure and sequence conservation of a putative hypoxia response element in the lactate dehydrogenase-B gene of Fundulus. Biol Bull (2001) 0.93
Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc (2004) 0.90
Prediction of survival for patients with fulminant hepatic failure. Hepatology (2005) 0.87
Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol (1998) 0.86
Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice. Lab Invest (2003) 0.86
Alterations in total lactate dehydrogenase and its isoenzyme-5 in hepatic disorders. Ann Clin Lab Sci (1990) 0.85
Serum enzyme activity evaluated in budgerigars (Melopsittacus undulatus) inflicted with muscle injury. Res Vet Sci (1993) 0.78
Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol (2009) 4.78
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50
Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat Genet (2007) 4.24
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet (2011) 4.04
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. J Hepatol (2012) 2.91
Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes (2009) 2.54
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer (2014) 2.45
Gli2 trafficking links Hedgehog-dependent activation of Smoothened in the primary cilium to transcriptional activation in the nucleus. Proc Natl Acad Sci U S A (2009) 2.43
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology (2003) 2.38
Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem (2003) 2.12
ProMode: a database of normal mode analyses on protein molecules with a full-atom model. Bioinformatics (2004) 1.89
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med (2007) 1.89
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int (2010) 1.88
Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation (2010) 1.66
STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif. Mol Biol Cell (2003) 1.63
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med (2008) 1.60
Prospective comparative study on the acceptability of unsedated transnasal endoscopy in younger versus older patients. J Clin Gastroenterol (2008) 1.54
Reevaluation of the association of seven candidate genes with blood pressure and hypertension: a replication study and meta-analysis with a larger sample size. Hypertens Res (2012) 1.51
Long-term fibrate treatment for PBC. J Gastroenterol (2005) 1.48
Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. J Exp Med (2010) 1.44
Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. J Biol Chem (2007) 1.43
Song memory in female birds: neuronal activation suggests phonological coding. Neuroreport (2010) 1.43
Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res (2004) 1.43
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia. J Clin Psychopharmacol (2015) 1.42
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol (2014) 1.39
Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun (2005) 1.37
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data. Mol Cell Proteomics (2013) 1.34
Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet (2011) 1.32
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res (2008) 1.31
Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am J Physiol Cell Physiol (2004) 1.28
The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab (2008) 1.28
Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun (2004) 1.28
Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans. Environ Health Perspect (2007) 1.27
Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA (2007) 1.25
Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells. Blood (2008) 1.25
Dietary patterns and A1C in Japanese men and women. Diabetes Care (2008) 1.25
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol (2009) 1.22
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism (2012) 1.22
Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr (2008) 1.19
Molecular recognition in dimerization between PB1 domains. J Biol Chem (2003) 1.18
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab (2005) 1.17
Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol (2007) 1.15
Nature of white opaque substance in gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging. Dig Endosc (2012) 1.15
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J Hepatol (2004) 1.13
Elovl6 promotes nonalcoholic steatohepatitis. Hepatology (2012) 1.13
Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med (2005) 1.11
Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma. World J Gastroenterol (2005) 1.10
High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int (2005) 1.09
Structure of a cell polarity regulator, a complex between atypical PKC and Par6 PB1 domains. J Biol Chem (2004) 1.09
Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc (2008) 1.08
Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract (2010) 1.08
Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat Commun (2011) 1.08
Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int J Mol Med (2009) 1.08
WURCS: the Web3 unique representation of carbohydrate structures. J Chem Inf Model (2014) 1.07
A role for Hrs in endosomal sorting of ligand-stimulated and unstimulated epidermal growth factor receptor. Exp Cell Res (2004) 1.07
Sorting of GPI-anchored proteins into ER exit sites by p24 proteins is dependent on remodeled GPI. J Cell Biol (2011) 1.06
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem (2003) 1.05
The cell polarity protein mInsc regulates neutrophil chemotaxis via a noncanonical G protein signaling pathway. Dev Cell (2013) 1.05
Herbicide atrazine activates SF-1 by direct affinity and concomitant co-activators recruitments to induce aromatase expression via promoter II. Biochem Biophys Res Commun (2007) 1.04
Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol (2007) 1.04
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy. J Hepatol (2013) 1.03
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of peripancreatic tuberculous lymphadenitis. J Gastroenterol (2007) 1.02
Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol (2004) 1.02
CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci (2010) 1.02
Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol (2013) 1.02
Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res (2010) 1.01
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C. J Hepatol (2013) 1.00
Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep (2011) 1.00